Connect Biopharma Holdings Limited Ordinary Shares (CNTB)
Stock · NASDAQ · Health Care
$2.23as of 8/28/2026
Price chart
Open in TradingViewActive signals
About CNTB
Connect Biopharma Holdings Limited operates as a clinical-stage biopharmaceutical company in the United States. It develops rademikibart, a human monoclonal IgG4 antibody directed against IL-4Ra in two Phase 2 trials for the treatment of acute exacerbations of asthma and chronic obstructive pulmonary disease (COPD). The company was founded in 2012 and is headquartered in San Diego, California.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 64
- Website
- www.connectbiopharm.com
Fundamentals
- 1-day range
- $2.21$2.32
- Market cap
- $124.04M
- P/E (trailing)
- —
- P/E (forward)
- -2.99
- EPS (trailing)
- $-1.15
- Dividend yield
- —
- Beta
- -0.20
- Avg. volume
- 460.5K
How Connect Biopharma Holdings Limited Ordinary Shares Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 31, 2026 · via SEC EDGAR / Finnhub
Forecasts
8 analyst ratings
Connect Biopharma Holdings Limited Ordinary Shares Competitors
Chosen by industry and closest market cap.
- CNTBConnect Biopharma Holdings Limited Ordinary Shares$2.22▼ 2.63%Market cap $124.04MP/E —$1.23$3.82
- IFRXInflaRx N.V. Common Stock$2.22▼ 2.20%Market cap $126.51MP/E —$0.7984$2.95
- PMNProMIS Neurosciences Inc. Common Shares (ON)$13.79▼ 1.43%Market cap $126.80MP/E —$6.27$27.4
- VTVTvTv Therapeutics Inc. Class A Common Stock$32.17▼ 1.92%Market cap $127.58MP/E 55.59$15.79$44
- SPRBSpruce Biosciences Inc. Common Stock$60.05▼ 5.13%Market cap $118.73MP/E —$7$240
- BGMBGM Group Ltd. Class A Ordinary Shares$0.3251▲ 11.34%Market cap $116.58MP/E —$0.2287$11.8
- ADCTADC Therapeutics SA Common Shares$1.15▲ 2.68%Market cap $133.55MP/E —$0.7796$4.98
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| CNTB Connect Biopharma Holdings Limited Ordinary Shares | $124.04M | — | $2.22 | ▼ 2.63% | $1.23$3.82 |
| IFRX InflaRx N.V. Common Stock | $126.51M | — | $2.22 | ▼ 2.20% | $0.7984$2.95 |
| PMN ProMIS Neurosciences Inc. Common Shares (ON) | $126.80M | — | $13.79 | ▼ 1.43% | $6.27$27.4 |
| VTVT vTv Therapeutics Inc. Class A Common Stock | $127.58M | 55.59 | $32.17 | ▼ 1.92% | $15.79$44 |
| SPRB Spruce Biosciences Inc. Common Stock | $118.73M | — | $60.05 | ▼ 5.13% | $7$240 |
| BGM BGM Group Ltd. Class A Ordinary Shares | $116.58M | — | $0.3251 | ▲ 11.34% | $0.2287$11.8 |
| ADCT ADC Therapeutics SA Common Shares | $133.55M | — | $1.15 | ▲ 2.68% | $0.7796$4.98 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- 12 Health Care Stocks Moving In Monday's After-Market SessionBenzinga · 8/24/2026
- Connect Biopharma Expects Topline Results From Phase 2 Seabreeze STAT Studies In September 2026benzinga · 8/12/2026
Insider Activity
Insider Actions →- Kleanthis Gabriel Xanthopoulos · June 30, 2026 · Grant3.7K
- Jean I. Liu · June 30, 2026 · Grant6.7K
- James Huang · May 29, 2026 · Buy150.0K @ $2.48
- Kleanthis Gabriel Xanthopoulos · March 31, 2026 · Grant2.8K
- Jean I. Liu · March 31, 2026 · Grant5.1K
- James Huang · March 31, 2026 · Buy1.16M @ $3.45
See the full, filterable feed with live charts on the MarketWall dashboard.